Vitality Watch

⚠ Evidence note: Most trends in this area rest on anecdote and mechanism; where real evidence exists it is usually for narrower claims than the trend makes.

Mentioned 1× · first seen 07-oct-2026 · last seen 07-oct-2026

Myostatin Inhibitors in Longevity Practice

Current understanding

To be populated as evidence accumulates.

Evidence log

Open questions

Related

Contributing findings

pubmed trial early human-rct
Trevogrumab (anti-GDF8) with or without garetosmab (anti-activin A) for prevention of muscle loss during semaglutide-induced weight reduction in people with obesity (COURAGE): a two-part, phase 2, double-blind, placebo-controlled, randomised trial.
11-nov-2026 novelty 4 per-area 4 strengthens
rss expert media expert-opinion
Myostatin inhibitors and the paradox of larger but weaker muscles
03-oct-2026 novelty 3 per-area 3 strengthens

build build 880 · 2bcef25 · 2026-11-18